News

Roche’s Lung Cancer Drug Combination Shows Promising Results

1 Mins read

Shares of Roche Holding have surged following the release of interim results from a late-stage clinical trial involving a combination of two of its drugs for lung cancer patients. The trial demonstrated a benefit for overall survival, leading to a 4.5% increase in Roche’s nonvoting shares.

Positive Interim Results

According to Roche, patients who received the immunotherapy tiragolumab in combination with the antibody Tecentriq showed an estimated median overall survival of 22.9 months. In comparison, patients who received Tecentriq alone had a median overall survival of 16.7 months. However, Roche advises caution as these results are still considered immature.

Potential Overall Survival Benefit

Citi analysts have stated that the ongoing phase 3 trial is on track to show a significant overall survival benefit. However, there are concerns regarding the data from the arm of the trial that received Tecentriq alone. Roche failed to replicate the median survival rate previously achieved in another trial with Tecentriq, which may limit its commercial impact.

Unintended Data Disclosure

Roche provided this progress update following an inadvertent disclosure of analysis data. The trial remains blinded to both patients and investigators and will continue until the final analysis for overall survival is completed. The company expects to release the final analysis in December.

It is worth highlighting that the initial goal of the lung-cancer trial was to achieve progression-free survival. Although this target was not met, the positive results for overall survival offer hope for lung cancer patients.

Related posts
News

Binance Founder CZ Clarifies BNB Trade Activity and Market Strategy

1 Mins read
On October 12, Binance’s founder Changpeng Zhao confirmed via X that BNB lacks market makers, highlighting its deflationary nature and community-driven development….
News

Aussies go viral for booing American national anthem at WWE Crown Jewel event in Perth

3 Mins read
7NEWS brings you the latest local news from Australia and around the world. Stay up to date with all of the breaking…
News

Bitcoin extends decline to $104,782 as Trump escalates US-China trade war | Today Headline

1 Mins read
(Reuters) -Bitcoin, the world’s largest cryptocurrency by market value, extended declines on Friday after U.S. President Donald Trump escalated his trade conflict…

Leave a Reply

Your email address will not be published. Required fields are marked *